Get access to our best features
Get access to our best features
Published 26 days ago

Amphastar Pharmaceuticals Interested In Potential Acquisitions In Endocrinology-Focused Companies - Eli Lilly and Co (NYSE:LLY), Amphastar Pharma (NASDAQ:AMPH)

Summary by Benzinga
At the Needham Healthcare Conference, Amphastar Pharmaceuticals Inc (NASDAQ:AMPH) highlighted why they remain excited about Baqsimi, the inhaled glucagon product for severe hypoglycemia.  Amphastar Pharmaceuticals develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products. Needham says the company still believes Baqsimi is the best glucagon product based on its expertise, which is difficult…

0 Articles

All
Left
Center
Right
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe
Ground News Article Assistant
Not enough coverage to generate an Article Assistant.

Bias Distribution

  • 100% of the sources are Center
100% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)